PMS27 A COST-EFFECTIVENESS ANALYSIS FROM AN INSTITUTIONAL PERSPECTIVE TO COMPARE ZOLEDRONIC ACID WITH STANDARD OF CARE IN THE PREVENTION OF HIP FRACTURES IN PATIENTS WITH OSTEOPOROSIS
May 1, 2011, 00:00 AM
10.1016/j.jval.2011.02.712
https://www.valueinhealthjournal.com/article/S1098-3015(11)00851-5/fulltext
Section Title :
Disease-Specific Studies
Section Order :
174
First Page :
A128
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00851-5&doi=10.1016/j.jval.2011.02.712